RE: >99% Sensitivity and Specificity18 Jun 2020 08:51
All, please take the time to listen to the Webinar. Prior to last night there was big question mark regarding whether the LFT could be a success. My own belief was that anything over 80% (e.g. better than the nearest competition) would have been good enough to generate transformational revenues. Post last night, I really do believe they are on track for >99% accuracy and would urge all to listen and make their own minds up.
Why would Klaus states that 95% accuracy would not be good enough for Mass screening but state later that 99% would be doable.
It seems probable that they have reached 99% specificity and sensitivity, meaning absolute best in class.
If, as they all predicted, 100s of millions of tests per month would be required, AVCT, with a best in class test, would have a majority market share
Quite honestly that is unbelievable. I don't want to ramp this too much but any pervious predictions on share price performance should be ripped up as whatever your were targeting should now be x at least 10 fold.